How are estrogen dominance and lupus related?

Signs of urogenital complaints

  1. Gandhi, J., et al. (2016, Dec). Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol, 215 (6), pp. 704-11.

  2. Neves-E-Castro, et al. (2015, May). EMAS position statement: The ten point guide to the integral management of menopausal health. Maturitas, 81 (1), pp. 88-92.

  3. Palma, F., et al. (2016, Jan). Vaginal atrophy of women in postmenopause. Results from amulticentric observational study: The AGATA study. Maturitas, 83, pp. 40-4.

  4. van Geelen, J., van de Weijer, P., & Arnolds, H. (2000). Urogenital symptoms and resulting discomfort in non-institutionalized Dutch women aged 50-75 years. Int Urogynecol J Pelvic Floor Dysfunct, 11 (1), pp. 9-14.

  5. Stenberg, A., Heimer, G., Ulmsten, U., & Cnattingius, S. (1996, May). Prevalence of genitourinary and other climacteric symptoms in 61-year-old women. Maturitas, 24, pp. 31-6.

  6. Stadberg, E., Mattsson, L., & Milsom, I. (1997, May). The prevalence and severity of climacteric symptoms and the use of different treatment regimens in a Swedish population. Acta Obstet Gynecol Scand, 76 (5), pp. 442-8.

  7. Dennerstein, L., Dudley, E., Hopper, J., & Guthrie, J.B. (2000, Sep). A prospective population-based study of menopausal symptoms. Obstet Gynecol, 96 (3), pp. 351-8.

  8. Nappi, R., & Kokot-Kierepa, M. (2010, Nov). Women's voices in the menopause: results from an international survey on vaginal atrophy. Maturitas, 67 (3), pp. 233-8.

  9. Stute, P., & Kiesel, L. (2007). Local estrogen therapy in menopause. Gynecol Endokrinol, 5, pp. 150-6.

  10. Caillouette, J., Sharp, C. J., Zimmerman, G., & Roy, S. (1997, Jun). Vaginal pH as a marker for bacterial pathogens and menopausal status. Am J Obstet Gynecol, 176 (6), pp. 1270-5.

  11. Birtalan, I. (1999). Estring - a new local estrogen therapy for vaginal and urogenital atrophy. J for menopause, 6, pp. 17-21.

  12. Cardozo, L., Benness, C., & Abbott, D. (1998, Apr). Low dose estrogen prophylaxis for recurrent urinary tract infections in elderly women. Br J Obstet Gynaecol, 105 (4), pp. 403-7.

  13. Robinson, D., & Cardozo, L. (2003, Mar). The menopause and HRT. Urogenital effects of hormone therapy. Best Pract Res Clin Endocrinol Metab, 17 (1), pp. 91-104.

  14. Dessole, S., et al. (2004, Jan-Feb). Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women. Menopause, 11 (1), pp. 49-56.

  15. Viereck, V., et al. (Apr 2000). Genitourinary aging. Reproduktionsmed, 16 (2), pp. 90-102.

  16. Blakeman, P., Hilton, P., & Bulmer, J. (1996). Estrogen status and cell cycle activity in the female lower urinary tract. Neurourol Urodyn, 15, pp. 325-6.

  17. Versi, E., & Cardozo, L. (1986). Urethral instability: diagnosis based on variations in the maximum urethral pressure in normal climacteric women. Neurourol Urodyn, 5, pp. 535-41.

  18. Jackson, S., et al. (1996). The effect of estradiol on vaginal collagen in postmenopausal women with stress urinary incontinence. Neurourol Urodyn, 15, pp. 327-8.

  19. Fantl, J. (1998). Postmenopausal urinary incontinence: comparison between non-estrogen and estrogen supplemented women. Obstet Gynecol, 71, pp. 823-8.

  20. Screiter, F., Fuchs, P., & Stockamp, ​​K. (1976). Estrogenic sensitivity of alpha receptors in the urethral musculature. Urol Int, 31, pp. 13-9.

  21. Van Geelen, J., Doesburg, W., Thomas, C., & Martin, C. J. (1981, Oct). Urodynamic studies in the normal menstrual cycle: the relationship between hormonal changes during the menstrual cycle and the urethral pressure profile. Am J Obstet Gynecol, 141 (4), pp. 384-92.

  22. Hextall, A., & Cardozo, L. (2001). The role of estrogen supplementation in lower urinary tract dysfunction. Int Urogynecol J Pelvic Floor Dysfunct, 12 (4), pp. 258-61.

  23. Marshall, S., & Linfoot, J. (1977, Jun). Influence of hormones on urinary tract infection. Therapeutic implications. Urology, 9 (6), pp. 675-9.

  24. Yoshimura, T., & Okamura, H. (2001, Sep). Short term oral estriol treatment restores normal premenopausal vaginal flora to elderly women. Maturitas, 39 (3), pp. 253-7.

  25. Petri, E. (2000). Urinary tract infections. In E. Petri (Ed.), Gynäkologische Urologie (pp. 195-212). Stuttgart, New York: Thieme.

  26. Sturdee, D., Panay, N., & Society, i. N. (2010). Recommendations for dealing with postmenopausal vaginal atrophy, October 1, 2010. J Gynäkol Endokrinol, 13 (4), pp. 8-21.

  27. Laumann, E., et al. (2005, Jan-Feb). Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res, 17 (1), pp. 39-57.

  28. De Leo, V., Caruso, S., Scolaro, V., & Cianci, A. (2009, Oct). Low dose oral contraceptives: 30 microg are still used? Minerva Ginecol, 61 (5), pp. 453-8.

  29. Mares, P., Hoffet, M., Rousseau, O., & Ripart-Neveu, S. (2001, Jan). Vaginal dryness. Rev Prat, 51 (2), pp. 155-8.

Gandhi, J., et al. (2016, Dec). Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol, 215 (6), pp. 704-11.
Neves-E-Castro, et al. (2015, May). EMAS position statement: The ten point guide to the integral management of menopausal health. Maturitas, 81 (1), pp. 88-92.
Palma, F., et al. (2016, Jan). Vaginal atrophy of women in postmenopause. Results from amulticentric observational study: The AGATA study. Maturitas, 83, pp. 40-4.
van Geelen, J., van de Weijer, P., & Arnolds, H. (2000). Urogenital symptoms and resulting discomfort in non-institutionalized Dutch women aged 50-75 years. Int Urogynecol J Pelvic Floor Dysfunct, 11 (1), pp. 9-14.
Stenberg, A., Heimer, G., Ulmsten, U., & Cnattingius, S. (1996, May). Prevalence of genitourinary and other climacteric symptoms in 61-year-old women. Maturitas, 24, pp. 31-6.
Stadberg, E., Mattsson, L., & Milsom, I. (1997, May). The prevalence and severity of climacteric symptoms and the use of different treatment regimens in a Swedish population. Acta Obstet Gynecol Scand, 76 (5), pp. 442-8.
Dennerstein, L., Dudley, E., Hopper, J., & Guthrie, J.B. (2000, Sep). A prospective population-based study of menopausal symptoms. Obstet Gynecol, 96 (3), pp. 351-8.
Nappi, R., & Kokot-Kierepa, M. (2010, Nov). Women's voices in the menopause: results from an international survey on vaginal atrophy. Maturitas, 67 (3), pp. 233-8.
Stute, P., & Kiesel, L. (2007). Local estrogen therapy in menopause. Gynecol Endokrinol, 5, pp. 150-6.
Caillouette, J., Sharp, C. J., Zimmerman, G., & Roy, S. (1997, Jun). Vaginal pH as a marker for bacterial pathogens and menopausal status. Am J Obstet Gynecol, 176 (6), pp. 1270-5.
Birtalan, I. (1999). Estring - a new local estrogen therapy for vaginal and urogenital atrophy. J for menopause, 6, pp. 17-21.
Cardozo, L., Benness, C., & Abbott, D. (1998, Apr). Low dose estrogen prophylaxis for recurrent urinary tract infections in elderly women. Br J Obstet Gynaecol, 105 (4), pp. 403-7.
Robinson, D., & Cardozo, L. (2003, Mar). The menopause and HRT. Urogenital effects of hormone therapy. Best Pract Res Clin Endocrinol Metab, 17 (1), pp. 91-104.
Dessole, S., et al. (2004, Jan-Feb). Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women. Menopause, 11 (1), pp. 49-56.
Viereck, V., et al. (Apr 2000). Genitourinary aging. Reproduktionsmed, 16 (2), pp. 90-102.
Blakeman, P., Hilton, P., & Bulmer, J. (1996). Estrogen status and cell cycle activity in the female lower urinary tract. Neurourol Urodyn, 15, pp. 325-6.
Versi, E., & Cardozo, L. (1986). Urethral instability: diagnosis based on variations in the maximum urethral pressure in normal climacteric women. Neurourol Urodyn, 5, pp. 535-41.
Jackson, S., et al. (1996). The effect of estradiol on vaginal collagen in postmenopausal women with stress urinary incontinence. Neurourol Urodyn, 15, pp. 327-8.
Fantl, J. (1998). Postmenopausal urinary incontinence: comparison between non-estrogen and estrogen supplemented women. Obstet Gynecol, 71, pp. 823-8.
Screiter, F., Fuchs, P., & Stockamp, ​​K. (1976). Estrogenic sensitivity of alpha receptors in the urethral musculature. Urol Int, 31, pp. 13-9.
Van Geelen, J., Doesburg, W., Thomas, C., & Martin, C. J. (1981, Oct). Urodynamic studies in the normal menstrual cycle: the relationship between hormonal changes during the menstrual cycle and the urethral pressure profile. Am J Obstet Gynecol, 141 (4), pp. 384-92.
Hextall, A., & Cardozo, L. (2001). The role of estrogen supplementation in lower urinary tract dysfunction. Int Urogynecol J Pelvic Floor Dysfunct, 12 (4), pp. 258-61.
Marshall, S., & Linfoot, J. (1977, Jun). Influence of hormones on urinary tract infection. Therapeutic implications. Urology, 9 (6), pp. 675-9.
Yoshimura, T., & Okamura, H. (2001, Sep). Short term oral estriol treatment restores normal premenopausal vaginal flora to elderly women. Maturitas, 39 (3), pp. 253-7.
Petri, E. (2000). Urinary tract infections. In E. Petri (Ed.), Gynäkologische Urologie (pp. 195-212). Stuttgart, New York: Thieme.
Sturdee, D., Panay, N., & Society, i. N. (2010). Recommendations for dealing with postmenopausal vaginal atrophy, October 1, 2010. J Gynäkol Endokrinol, 13 (4), pp. 8-21.
Laumann, E., et al. (2005, Jan-Feb). Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res, 17 (1), pp. 39-57.
De Leo, V., Caruso, S., Scolaro, V., & Cianci, A. (2009, Oct). Low dose oral contraceptives: 30 microg are still used? Minerva Ginecol, 61 (5), pp. 453-8.
Mares, P., Hoffet, M., Rousseau, O., & Ripart-Neveu, S. (2001, Jan). Vaginal dryness. Rev Prat, 51 (2), pp. 155-8.